CHARLES J WHALEN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology FORT WAYNE, IN NPI 1245232156
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology IN Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$4,149.74
- Category: General Payments
- Program years: PY2018–2023
- Record count: 174
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $701.70 across 29 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $701.70 | 29 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $166.37 | 3 |
| GENZYME CORPORATION | $78.01 | 3 |
| Merck Sharp & Dohme Corporation | $51.95 | 3 |
| Alexion Pharmaceuticals, Inc. | $31.43 | 1 |
| PFIZER INC. | $31.11 | 2 |
| TerSera Therapeutics LLC | $28.55 | 1 |
| Daiichi Sankyo Inc. | $27.38 | 1 |
| Adaptive Biotechnologies Corporation | $25.56 | 1 |
| Celgene Corporation | $23.66 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $21.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.94 | 1 |
| Rigel Pharmaceuticals, Inc. | $19.74 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.73 | 1 |
| Acerta Pharma LLC | $19.65 | 1 |
| TAIHO ONCOLOGY, INC. | $19.37 | 1 |
| Aadi Bioscience, Inc. | $19.17 | 1 |
| Novocure Inc. | $17.96 | 1 |
| ImmunoGen, Inc. | $17.12 | 1 |
| Exelixis Inc. | $16.53 | 1 |
| Gilead Sciences, Inc. | $15.67 | 1 |
| Astellas Pharma US Inc | $15.10 | 1 |
| Genentech USA, Inc. | $14.95 | 1 |
By program year
Records — PY2023 (29)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.